Infrared spectra were acquired on a spectrometer (Vertex 70v FTIR, Bruker, Billerica, MA, USA) using diamond crystal attenuated total reflection (ATR) in a wavenumber range of 400 to 4000 cm-1.

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

The stock’s 50-day simple moving average is $57.14 and its two-hundred day simple moving average is $60.24. Bruker has a twelve month low of $48.07 and a twelve month high of $94.86. Bruker ...

BILLERICA, Mass. (AP) — BILLERICA, Mass. (AP) — Bruker Corp. (BRKR) on Thursday reported fourth-quarter earnings of $13.7 million. The Billerica, Massachusetts-based company said it had profit ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

Bruker exceeded both EPS and revenue forecasts for Q4 2024. The company reported a 14.6% year-over-year increase in quarterly revenue. Stock price decreased by 0.77% despite the earnings beat ...

The wholesale cost for Vertex’s twice-daily medicine is set at $15.50 per 50 milligram tablet. Vertex’s drug was approved to treat moderate-to-severe acute pain. The company has been pushing ...

(3) Bruker Scientific Instruments (BSI) revenue reflects the sum of the BSI BioSpin, CALID and Nano Segments as presented in our Annual Report on Form 10-K for the year ended December 31 ...

On February 25, 2025, Bruker Corporation (NASDAQ:BRKR) stock closed at $50.99 per share with a market capitalization of $7.73 billion. The London Company SMID Cap Strategy stated the following ...

At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown its team year-over-year. At a time when many life sciences companies are ...

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting.